Outcomes of melanoma in recipients of solid organ transplant

Journal of the American Academy of Dermatology

Volumn 59, Issue 3, 2008, Pages 405-417

  Dapprich, Daniel C ^a   Weenig, Roger H ^a   Rohlinger, Audrey L ^a   Weaver, Amy L ^a   Lim Quan, Katherine K ^a   Keeling, James H ^b   Walsh, John S ^b   Otley, Clark C ^a   Christenson, Leslie J ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; MALE; MEDICAL RECORD; MELANOMA; METASTASIS; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT CANCER;

ADULT; AGED; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; KAPLAN-MEIERS ESTIMATE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGAN TRANSPLANTATION; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN; SKIN NEOPLASMS; TIME FACTORS; UNITED STATES;

EID: 48749119829     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.05.015     Document Type: Article

References (39)

1. Balch C.M., Buzaid A.C., Soong S.J., Atkins M.B., Cascinelli N., Coit D.G., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 (2001) 3635-3648
2. Clemente C.G., Mihm Jr. M.C., Bufalino R., Zurrida S., Collini P., and Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77 (1996) 1303-1310
3. Menzies S.W., and McCarthy W.H. Complete regression of primary cutaneous malignant melanoma. Arch Surg 132 (1997) 553-556
4. + T cells. World J Surg 19 (1995) 352-358
5. Kawakami Y., Eliyahu S., Delgado C.H., Robbins P.F., Rivoltini L., Topalian S.L., et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci U S A 91 (1994) 3515-3519
6. Marshall J.A., Forster T.H., Purdie D.M., Lanagan C.M., O'Connor L.E., O'Rourke M.G., et al. Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma. Immunol Cell Biol 84 (2006) 295-302
7. Lindelof B., Sigurgeirsson B., Gabel H., and Stern R.S. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143 (2000) 513-519
8. Le Mire L., Hollowood K., Gray D., Bordea C., and Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol 154 (2006) 472-477
9. Rodrigues L.K., Klencke B.J., Vin-Christian K., Berger T.G., Crawford R.I., Miller III J.F., et al. Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol 138 (2002) 765-770
10. McKenna D.B., Stockton D., Brewster D.H., and Doherty V.R. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 88 (2003) 74-78
11. Hariharan S., Johnson C.P., Bresnahan B.A., Taranto S.E., McIntosh M.J., and Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342 (2000) 605-612
12. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl (1994) 99-109
13. National Cancer Institute. 51-Year trends in US cancer death rates: SEER cancer statistics review, 1975-2000. Available from: URL:http://seer.cancer.gov/csr/1975_2000/results_merged/topic_inc_mor_trends.pdf. Accessed May 10, 2006.
14. de Vries E., Bray F.I., Coebergh J.W., and Parkin D.M. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 107 (2003) 119-126
15. Stang A., and Jockel K.H. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol 13 (2003) 436-442
16. Coory M., Baade P., Aitken J., Smithers M., McLeod G.R., and Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 17 (2006) 21-27
17. Baade P., and Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health 29 (2005) 383-386
18. Balch C.M., Buzaid A.C., Soong S.J., Atkins M.B., Cascinelli N., Coit D.G., et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 21 (2003) 43-52
19. Cassarino D.S., Cabral E.S., Kartha R.V., and Swetter S.M. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma. Arch Dermatol 144 (2008) 49-56
20. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 61 (1996) 274-278
21. Leveque L., Dalac S., Dompmartin A., Louvet S., Euvrard S., Catteau B., et al. Melanoma in organ transplant patients. [in French]. Ann Dermatol Venereol 127 (2000) 160-165
22. Greene M.H., Young T.I., and Clark Jr. W.H. Malignant melanoma in renal-transplant recipients. Lancet 1 (1981) 1196-1199
23. Oliver R.T., and Nouri A.M. T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy. Cancer Surv 13 (1992) 173-204
24. Lee P.P., Yee C., Savage P.A., Fong L., Brockstedt D., Weber J.S., et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5 (1999) 677-685
25. Neri B., Vannozzi L., Fulignati C., Pantaleo P., Pantalone D., Paoletti C., et al. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a phase II study. Cancer Invest 24 (2006) 474-478
26. Herman M., Weinstein T., Korzets A., Chagnac A., Ori Y., Zevin D., et al. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med 137 (2001) 14-20
27. Hojo M., Morimoto T., Maluccio M., Asano T., Morimoto K., Lagman M., et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397 (1999) 530-534
28. Maluccio M., Sharma V., Lagman M., Vyas S., Yang H., Li B., et al. Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression. Transplantation 76 (2003) 597-602
29. Geissler E.K., and Schlitt H.J. The relation between immunosuppressive agents and malignancy. Curr Opin Organ Transplant 9 (2004) 394-399
30. Goldstein A.M., and Tucker M.A. Genetic epidemiology of familial melanoma. Dermatol Clin 13 (1995) 605-612
31. Haluska F.G., and Hodi F.S. Molecular genetics of familial cutaneous melanoma. J Clin Oncol 16 (1998) 670-682
32. Benvenuto-Andrade C., Oseitutu A., Agero A.L., and Marghoob A.A. Cutaneous melanoma: surveillance of patients for recurrence and new primary melanomas. Dermatol Ther 18 (2005) 423-435
33. Penn I. Transmission of cancer from organ donors. Ann Transplant 2 (1997) 7-12
34. Stephens J.K., Everson G.T., Elliott C.L., Kam I., Wachs M., Haney J., et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 70 (2000) 232-236
35. Morris-Stiff G., Steel A., Savage P., Devlin J., Griffiths D., Portman B., et al. Welsh Transplantation Research Group. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 4 (2004) 444-446
36. MacKie R.M., Reid R., and Junor B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med 348 (2003) 567-568
37. Birkeland S.A., and Storm H.H. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation 74 (2002) 1409-1413
38. Buell J.F., Trofe J., Hanaway M.J., Lo A., Rosengard B., Rilo H., et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 130 (2001) 660-666
39. Weinstock M.A., Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., and Speizer F.E. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol 133 (1991) 240-245